Active, Not Recruiting
Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
NCT03428802
- Conditions
- Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +40 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States